Addition of bevacizumab to systemic therapy for locally advanced and metastatic nasopharyngeal carcinoma.

about

Addition of bevacizumab to systemic therapy for locally advanced and metastatic nasopharyngeal carcinoma.

Item

http://www.wikidata.org/entity/Q55025647

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Addition of bevacizumab to sys ...... atic nasopharyngeal carcinoma.

@en

Addition of bevacizumab to sys ...... atic nasopharyngeal carcinoma.

@nl

type

Item

label

Addition of bevacizumab to sys ...... atic nasopharyngeal carcinoma.

@en

Addition of bevacizumab to sys ...... atic nasopharyngeal carcinoma.

@nl

prefLabel

Addition of bevacizumab to sys ...... atic nasopharyngeal carcinoma.

@en

Addition of bevacizumab to sys ...... atic nasopharyngeal carcinoma.

@nl

P1476

Addition of bevacizumab to sys ...... atic nasopharyngeal carcinoma.

@en

P2093

Gao-Le Yuan

http://www.w3.org/2001/XMLSchema#string

Hui-Jie Zhang

http://www.w3.org/2001/XMLSchema#string

Liang Jiang

http://www.w3.org/2001/XMLSchema#string

Qi-Lian Liang

http://www.w3.org/2001/XMLSchema#string

Shao-Ang Cheng

http://www.w3.org/2001/XMLSchema#string

Xiao-Xia Peng

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted Therapy in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (LA-R/M HNSCC)

Emerging treatment options for nasopharyngeal carcinoma

Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinoma

[Anti-nasopharyngeal carcinoma effect in vivo and in vitro of Avastin and adenovirus-thymidine kinase suicide gene].

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study

Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab

Effect of the vascular endothelial growth factor expression level on angiopoietin-2-mediated nasopharyngeal carcinoma growth.

Current management strategy of nasopharyngeal carcinoma.

Combining Bevacizumab with Radiation or Chemoradiation for Solid Tumors: A Review of the Scientific Rationale, and Clinical Trials.

Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.

P304

7799-7805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.8284

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29740494

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab

P932

5934720

http://www.w3.org/2001/XMLSchema#string